These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 14997205)

  • 21. Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors.
    Helenius MA; Savinainen KJ; Bova GS; Visakorpi T
    BJU Int; 2006 Feb; 97(2):404-9. PubMed ID: 16430655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8q24 amplification is associated with Myc expression and prostate cancer progression and is an independent predictor of recurrence after radical prostatectomy.
    Fromont G; Godet J; Peyret A; Irani J; Celhay O; Rozet F; Cathelineau X; Cussenot O
    Hum Pathol; 2013 Aug; 44(8):1617-23. PubMed ID: 23574779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
    Straub B; Müller M; Krause H; Schrader M; Miller K
    Urology; 2003 Jul; 62(1):172-6. PubMed ID: 12837461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics.
    Visscher DW; Wallis T; Awussah S; Mohamed A; Crissman JD
    Genes Chromosomes Cancer; 1997 Jan; 18(1):1-7. PubMed ID: 8993975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients.
    Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR
    Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
    Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
    J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amplification of urokinase gene in prostate cancer.
    Helenius MA; Saramäki OR; Linja MJ; Tammela TL; Visakorpi T
    Cancer Res; 2001 Jul; 61(14):5340-4. PubMed ID: 11454671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification and overexpression of Elongin C gene discovered in prostate cancer by cDNA microarrays.
    Porkka K; Saramäki O; Tanner M; Visakorpi T
    Lab Invest; 2002 May; 82(5):629-37. PubMed ID: 12004003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen receptor gene amplification and protein expression in recurrent prostate cancer.
    Ford OH; Gregory CW; Kim D; Smitherman AB; Mohler JL
    J Urol; 2003 Nov; 170(5):1817-21. PubMed ID: 14532783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel human MOST-1 (C8orf17) gene exhibits tissue specific expression, maps to chromosome 8q24.2, and is overexpressed/amplified in high grade cancers of the breast and prostate.
    Tan JM; Tock EP; Chow VT
    Mol Pathol; 2003 Apr; 56(2):109-15. PubMed ID: 12665628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays.
    Kauraniemi P; Bärlund M; Monni O; Kallioniemi A
    Cancer Res; 2001 Nov; 61(22):8235-40. PubMed ID: 11719455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
    Murthy SK; Magliocco AM; Demetrick DJ
    Arch Pathol Lab Med; 2005 Jan; 129(1):39-46. PubMed ID: 15628907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
    An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
    Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
    Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse.
    Giusiano S; Garcia S; Andrieu C; Dusetti NJ; Bastide C; Gleave M; Taranger-Charpin C; Iovanna JL; Rocchi P
    Prostate; 2012 Feb; 72(2):117-28. PubMed ID: 21538421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative quantification of ERBB2 mRNA in invasive duct carcinoma of the breast: correlation with ERBB-2 protein expression and ERBB2 gene copy number.
    Mrhalová M; Kodet R; Kalinová M; Hilská I
    Pathol Res Pract; 2003; 199(7):453-61. PubMed ID: 14521261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.